Work

A phase II trial cohort of nivolumab plus ipilimumab in patients (Pts) with recurrent/metastatic salivary gland cancers (R/M SGCs).

Year: 2021

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2021.39.15_suppl.6002

Authors: Bharat Burman, Eric Jeffrey Sherman, Lara Dunn, James Vincent Fetten, Loren S. Michel, Luc G.T. Morris, Irina Ostrovnaya, Sofia Haque, David G. Pfister, Alan Loh Ho

Institutions: Tufts University, Memorial Sloan Kettering Cancer Center, Washington University in St. Louis

Language: English

Topic: Salivary Gland Tumors Diagnosis and Treatment

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3172762490

Cites:

Cited by: 20

Related to: 10